IGF-1 administration in mouse models with methionine-choline-deficient diet-induced nonalcoholic steatohepatitis and dimethylnitrosamine-induced cirrhosis ameliorated hepatic steatosis, inflammation, and fibrosis (25). The gene discussed is IGF1; the disease is fatty liver disease.